Ensysce Biosciences Inc. is a clinical-stage biotechnology company headquartered in La Jolla, California, dedicated to pioneering transformative prescription drug solutions that tackle critical unmet medical needs. With a focus on innovative drug delivery technologies, Ensysce is actively developing pain management therapies aimed at mitigating the risks associated with opioid dependence. The company's commitment to pharmaceutical research and development underscores its potential to revolutionize pain management practices, positioning it as an attractive investment opportunity for institutional investors within the biopharmaceutical landscape.
Click "Analyze" to generate stock analysis
ENSC Price Trend and Signals
ENSC Financials
2025-12-11Somewhat Bearishprice_signal
Yearly low detected.
2025-12-09Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-12-09Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-12-09Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-12-09Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.